Hypoglossal Nerve Stimulator: A Novel Treatment Approach for OSA - Overview of Treatment, Including Diagnostic and Patient Criteria and Procedural Terminology Codes

Unilateral stimulation of the hypoglossal nerve may result in clinically valuable patency of the upper airway in well-selected patients for treatment of OSA. The Food and Drug Administration has established stringent criteria for the placement of this medical device. The treatment is a consideration among patients who have been nonadherent or intolerant of positive airway pressure therapy, with moderate to severe OSA, and a BMI of ≤ 32 kg/m . Some of the insurance providers have lowered BMI guidelines to allow implantation in patients with a BMI of